Literature DB >> 21537934

Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk.

Xiao-Feng He, Jiao Su, Ying Zhang, Da-Peng Ding, Wei Wang, Yi Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21537934     DOI： 10.1007/s10549-011-1537-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  2 in total

1.  Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

Authors:  Wei Li; Ke-Jia Liu; Jing-Song Song; Rui Song; Zi-Liang Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study.

Authors:  Florence Le Calvez-Kelm; Javier Oliver; Francesca Damiola; Nathalie Forey; Nivonirina Robinot; Geoffroy Durand; Catherine Voegele; Maxime P Vallée; Graham Byrnes; Breast Cancer Family Registry; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Sean V Tavtigian; Fabienne Lesueur
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.